Increased Risk to Develop Hypertension and Carotid Plaques in Patients with Long-Lasting Helicobacter pylori

Maria Pina Dore1,2, Pier Sergio Saba3, Giulia Tomassini1

  • 1Dipartimento di Scienze Mediche, Chirurgiche e Sperimentali, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy.

Insights

Long-lasting Helicobacter pylori infection is linked to increased hypertension risk and carotid plaques. This study analyzed patient records to confirm H. pylori as an independent risk factor for these conditions.

Area of Science:

  • Gastroenterology and Cardiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Helicobacter pylori infection is a common global pathogen.
  • Previous studies show conflicting associations between H. pylori and hypertension.
  • The link between H. pylori and cardiovascular conditions like carotid lesions requires further investigation.

Purpose of the Study:

  • To analyze the relationship between H. pylori infection and hypertension.
  • To investigate the association between H. pylori infection and atherosclerotic carotid lesions.
  • To determine if long-lasting H. pylori infection is an independent risk factor for these conditions.

Main Methods:

  • Retrospective analysis of 7152 patient records undergoing upper endoscopy and gastric biopsy.
  • Data collected included H. pylori status (current/past/long-lasting), hypertension, carotid lesions, BMI, smoking, diabetes, and dyslipidemia.
  • Multivariable regression models were used to adjust for confounders.

Main Results:

  • Long-lasting H. pylori infection was significantly associated with an increased risk of hypertension (OR 1.17).
  • Long-lasting H. pylori infection was an independent risk factor for carotid plaques (OR 2.15).
  • These associations remained significant after adjusting for age, sex, BMI, smoking, diabetes, and dyslipidemia.

Conclusions:

  • Long-lasting H. pylori infection is an independent risk factor for hypertension.
  • Long-lasting H. pylori infection is an independent risk factor for the presence of carotid lesions.
  • Further prospective studies are recommended to validate these findings.

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
306
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
571
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
646
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
630
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
744
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
214